Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of ASP7374-Open-label Study of Subcutaneous Vaccination of Quadrivalent ASP7374 in Adult Subjects Aged 20 or Older

NCT02366962 is registered in ClinicalTrials.gov with UMN Pharma Inc. as lead sponsor.

NCT NCT02366962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02366962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of ASP7374-Open-label Study of Subcutaneous Vaccination of Quadrivalent ASP7374 in Adult Subjects Aged 20 or Older
Lead sponsor
UMN Pharma Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2015
Completion date
April 30, 2015
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, vaccine